878 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Not yet recruiting Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer
Condition: Bronchial Cancer
Intervention: Device: With and without SDB
3 Recruiting Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients
Conditions: Carcinoma, Non-Small-Cell Lung;   Bronchial Neoplasms;   Carcinoma, Bronchogenic;   Lung Diseases;   Lung Neoplasms
Intervention:
4 Recruiting Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Conditions: Tumors;   Carcinoma, Bronchogenic;   Breast Carcinoma;   Cancer of Head and Neck;   Lymphoma, Malignant;   Soft Tissue Neoplasms
Intervention: Drug: 18F-Al-NOTA-PRGD2 PET/CT
5 Not yet recruiting International Lung Screen Trial (ILST)
Conditions: Non-small Cell Lung Cancer;   Lung Neoplasms;   Respiratory Tract Neoplasms;   Thoracic Neoplasms;   Neoplasms by Site;   Neoplasms;   Lung Diseases;   Respiratory Tract Diseases;   Smokers at Risk of Lung Cancer
Intervention: Radiation: Low dose CT
6 Recruiting Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
Conditions: Stage IA Non-small Cell Lung Cancer;   Adenocarcinoma of the Lung;   Squamous Cell Lung Cancer
Intervention:
7 Recruiting Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage IB and II Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Durvalumab;   Other: Durvalumab plus SBRT
8 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
9 Recruiting A Study of Daratumumab in Combination With Atezolizumab Compared With Atezolizumab Alone in Participants With Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Atezolizumab;   Drug: Daratumumab
10 Not yet recruiting Evaluation of a Food Intake Modification for Lung Cancer Patients
Conditions: Carcinoma, Non-Small-Cell Lung;   Antineoplastic Agents
Interventions: Other: Food Intake Modification;   Other: Habitual Food Intake
11 Not yet recruiting A Study of Durvalumab Versus Standard of Care in Advanced Non Small-Cell Lung Cancer
Condition: Non Small Cell Lung Carcinoma (NSCLC)
Interventions: Biological: Durvalumab (MEDI4736);   Drug: Paclitaxel + carboplatin;   Drug: Gemcitabine + cisplatin;   Drug: Gemcitabine + carboplatin;   Drug: Pemetrexed + cisplatin;   Drug: Pemetrexed + carboplatin
12 Not yet recruiting EGFR-TKI With/Without Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism
Conditions: Nonsmall Cell Lung Cancer;   EGFR Gene Mutation
Interventions: Drug: EGFR-TK Inhibitor;   Drug: EGFR-TKI;   Drug: EGFR-TKI and Chemotherapy
13 Recruiting Study to Investigate the Absorption, Metabolism and Excretion of [14C] AC0010 in Patients With Advanced NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: 14C-labeled AC0010 oral
14 Not yet recruiting Combination Study of Guadecitabine and Pembrolizumab.
Conditions: Castration-Resistant Prostatic Cancer;   Non Small Cell Lung Cancer
Interventions: Drug: Guadecitabine;   Drug: Pembrolizumab
15 Recruiting Single-port, Two-port Versus Three-port VATS on Non-small Cell Lung Cancer
Condition: Lung Neoplasm
Interventions: Procedure: Three-port pulmonary resection surgery;   Procedure: Single-port or two-port surgery
16 Not yet recruiting EGFR-TKI Resistance Profile in Chinese Patients With Advanced EGFRm+ NSCLC
Condition: Nonsmall Cell Lung Cancer
Intervention:
17 Recruiting A Phase II Study of Fruquintinib in Combination With Gefitinib in Patients With Advanced Non-small Cell Lung Cancer
Condition: NSCLC
Interventions: Drug: Fruquintinib;   Drug: Gefitinib
18 Not yet recruiting Phase II Trial of SBRT Compared With Conventional Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer
Condition: NSCLC
Interventions: Radiation: Conventional Fractionated Radiotherapy;   Radiation: Stereotactic Body Radiation Therapy
19 Not yet recruiting Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of Alflutinib in Advanced Non Small Cell Lung Cancer
Condition: NSCLC
Intervention: Drug: Alflutinib
20 Recruiting Extensive Stage Sclc Patients Who Were Benefit From First-line Treatment Accept Temozolomide Maintain Therapeutic
Condition: Extensive Stage Small Cell Lung Cancer
Intervention: Drug: temozolomide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.